There are no prerequisites, although previous knowledge of Pharmacology, Pharmacokinetics, Biostatistics and Bioinformatics is recommended.
The number of oncological drugs in clinical research is increasing each year, making it one of the main lines of health research, a truly dynamic field in continuous progress.
Because of its severity, prevalence and complexity, without losing sight of its economic impact, cancer patients are a priority for health systems.
The objective of the course is to prepare students to offer comprehensive pharmaceutical care to the onco-hematological patient, introducing the student to the use of the basic concepts, as well as the procedures, symptoms, diagnosis, treatment and care that should be addressed in this type of patient.
It is therefore intended to familiarize the student with the pharmaceutical intervention, as an improvement in the healthcare process of pharmacological treatment, as well as to convey to students the importance of quality and safety in the preparation, administration and dispensing of risk drugs.
SOCIO-SANITARY SITUATION: The contents and/or specific sections of this guide may be subject to modification if the social-health situation due to the pandemic requires it. In any case, students will be warned of such changes through the virtual campus. At the time of publication of the guide, all teaching possibilities are being considered (face-to-face, semi-face-to-face and/or online), which will be implemented according to the evolution of the health situation.
Course competences | |
---|---|
Code | Description |
B01 | Proficiency in a second foreign language at level B1 of the Common European Framework of Reference for Languages. |
B02 | Knowledge of Information and Communication Technologies (ICT). |
B03 | A correct oral and written communication |
B04 | Ethical commitment and professional deontology. |
B05 | Ability to develop those learning skills necessary to undertake further studies. |
EM01 | Using drugs safely, taking into account their physical properties and the kind of vehicles directly related with their use. |
EM04 | Study the effects of substances with pharmacological activity. |
EM05 | Know and understand the techniques used in the design and evaluation of pre-clinical and clinical trials. |
EM06 | Carry out clinical and social pharmacy activities, following the pharmaceutical care cycle. |
EM07 | Promote the rational use of medicines and health products. |
EM08 | Acquire the necessary skills to provide therapeutic advices in pharmacology and dietetics, as well as to give nutritional advice to the users of the establishment where they provide customer service |
EM09 | Understand the relationship between diet and health, and the importance of diet in the treatment and prevention of diseases. |
EM10 | Know and understand the management and characteristics of pharmaceutical assistance in Structures |
EM12 | Acquire a detailed knowledge about the drugs properties and their mechanism of action |
EM13 | Know and understand the structure and function of the human body, as well as the general mechanisms of disease, molecular, structural and functional alterations, syndromic expression and therapeutic tools to restore health. |
EM17 | Know the molecular, cellular and tissue components of the immune system. |
EM18 | Understand the recognition mechanisms and effector mechanisms involved in the innate and acquired immune response, as well as diseases associated with the Immune System and therapeutic tools aimed to the prevention and the recovery of health. |
EM19 | Understand the cellular and molecular bases and etiological mechanisms of immunological-based diseases |
EM20 | Know the analytical techniques related to immunological laboratory diagnosis: design, implement and comprehend the immunological techniques applied to research, health service or industry |
EM22 | Interaction of drugs with other drugs or substances. Prevention and treatment. |
G02 | Evaluate the therapeutic and toxic effects of substances with pharmacological activity. |
G03 | Know how to apply the scientific method and acquire skills in the handling of legislation, sources of information, bibliography, elaboration of protocols and other aspects considered necessary for the design and critical evaluation of preclinical and clinical trials. |
G04 | Design, prepare, supply and dispense medicines and other products of health interest. |
G06 | Promote the rational use of medicines and medical devices, as well as to acquire basic knowledge in clinical management, health economics and the efficient use of health resources. |
G07 | Identify, evaluate and assess problems related to drugs and medicines, as well as participate in pharmacovigilance activities. |
G08 | Conducting clinical and social pharmacy activities, following the pharmaceutical care cycle. |
G09 | Intervene in health promotion and disease prevention activities at the individual, family and community levels, with an integral and multi-professional vision of the health-disease process. |
G13 | Develop communication and information skills, both oral and written, to deal with patients and users of the centre where they carry out their professional activity. Promote the capacity to work and collaborate with multidisciplinary teams and those related to other health professionals. |
G14 | Know the ethical and deontological principles according to the legislative, regulatory and administrative provisions governing professional practice, understanding the ethical implications of health in a changing social context. |
G15 | Recognise own limitations and the need to maintain and update professional competence, with particular emphasis on self-learning of new knowledge based on scientific evidence. |
T01 | Critical thinking skills based on the application of the scientific method |
T02 | Ability to manage quality scientific information, bibliography, specialized databases and resources accessible through the Internet. |
T03 | Handling of basic and specific software for the treatment of information and experimental results. |
Course learning outcomes | |
---|---|
Description | |
The student will know and learn to consult Clinical Practice Guidelines and protocols in the field of oncohematology (NCCN, MASC, EORT, ASCO, ASHP). | |
The student will be trained in the management of oncological drugs and will know the differential characteristics regarding other pharmacological therapies. | |
The student will know the importance of education and advice to patients and caregivers to approach optimally their pharmacotherapeutic treatment established in the achievement of the therapeutic objectives decided together with the medical responsible for the patient. | |
The student will acquire the knowledge and skills necessary to design a pharmacotherapeutic plan that helps to predict, prevent and solve problems related to the treatment or illness of oncohematological patients. | |
The student will develop the knowledge and skills necessary to know how to integrate all the needs related to pharmacotherapy of the oncohematological patient. | |
The student will know the relevance of predictive and prognostic factors and their involvement in the development of anticancer treatments and strategies. | |
Additional outcomes | |
Description | |
They have not been established. |
Research and management of guidelines and protocols in the field of oncohaematology. Resolution of practical cases.
The material provided in class by the teacher is the teacher's intellectual material and may not be distributed by the student. Likewise, it is not permitted to record classes without the teacher's permission.
Training Activity | Methodology | Related Competences (only degrees before RD 822/2021) | ECTS | Hours | As | Com | Description | |
Class Attendance (theory) [ON-SITE] | Combination of methods | B01 B02 B03 B04 B05 EM01 EM04 EM05 EM06 EM07 EM08 EM09 EM10 EM12 EM13 EM17 EM18 EM19 EM20 EM22 G02 G03 G04 G06 G07 G08 G09 G13 G14 G15 T01 T02 T03 | 1.62 | 40.5 | Y | N | Face-to-face teaching combining different teaching methodologies: lecture/lecture method with case studies carried out in workshops and seminars throughout the course. The active participation of the student will be valued, through individual and cooperative work both in the classroom and outside it, through problem solving and the completion of work and presentations developed in workshops and seminars throughout the course that will be taken into account in the final assessment of the subject. Classroom teaching in which students will be provided with the teaching material necessary to follow the course in the form of PowerPoint presentations, collections of notes and activities that will be accessible on the Virtual Campus. They will also be indicated the most appropriate bibliography in each case. | |
Study and Exam Preparation [OFF-SITE] | Self-study | B01 B02 B03 B04 B05 EM10 EM12 EM13 EM17 EM18 EM19 EM20 EM22 G02 G03 G04 G06 G07 G08 G09 G13 G14 G15 T01 T02 T03 | 2.72 | 68 | Y | N | To facilitate autonomous work, students may request personal tutorials on the contents of the subject by arranging an interview with the teacher in advance. | |
Formative Assessment [ON-SITE] | Assessment tests | B01 B02 B03 B04 B05 EM10 EM12 EM13 EM17 EM18 EM19 EM20 EM22 G02 G03 G04 G06 G07 G08 G09 G13 G14 G15 T01 T02 T03 | 0.16 | 4 | Y | Y | Specific dates have been set aside in the academic calendar specific dates have been set aside in the so that the assessment tests do not assessment tests do not coincide with other teaching activities. | |
Total: | 4.5 | 112.5 | ||||||
Total credits of in-class work: 1.78 | Total class time hours: 44.5 | |||||||
Total credits of out of class work: 2.72 | Total hours of out of class work: 68 |
As: Assessable training activity Com: Training activity of compulsory overcoming (It will be essential to overcome both continuous and non-continuous assessment).
Evaluation System | Continuous assessment | Non-continuous evaluation * | Description |
Final test | 70.00% | 70.00% | Both the theoretical knowledge and the application of the same to the resolution of problems and practical cases are evaluated. |
Assessment of active participation | 30.00% | 30.00% | Where the realization of problems and activities proposed in class are valued, as well as the participation in the seminars and exhibition of works. The proposed activities will be available on the virtual campus. |
Total: | 100.00% | 100.00% |
Not related to the syllabus/contents | |
---|---|
Hours | hours |
Class Attendance (theory) [PRESENCIAL][Combination of methods] | 40.5 |
Study and Exam Preparation [AUTÓNOMA][Self-study] | 68 |
Formative Assessment [PRESENCIAL][Assessment tests] | 4 |
Global activity | |
---|---|
Activities | hours |